Global Information
회사소개 | 문의 | 비교리스트

Immune Response BioPharma, Inc. : 제품 파이프라인 리뷰

Immune Response BioPharma Inc - Product Pipeline Review - 2016

리서치사 Global Markets Direct
발행일 2016년 12월 상품 코드 319979
페이지 정보 영문 42 Pages
가격
US $ 1,500 ₩ 1,824,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,649,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,474,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


Immune Response BioPharma, Inc. : 제품 파이프라인 리뷰 Immune Response BioPharma Inc - Product Pipeline Review - 2016
발행일 : 2016년 12월 페이지 정보 : 영문 42 Pages

Immune Response BioPharma, Inc.는 미국에 본사를 둔 제약 기업으로 자가면역 질환이나 감염증을 대상으로 한 백신을 개발하고 있습니다. 제품은 다발성 경화증, 폐혈성 쇼크, HIV/AIDS, 류마티스 관절염, 크론병, 건선, 통풍, 당뇨병, 심장 질환 등의 치료에 사용되고 있습니다.

Immune Response BioPharma, Inc.의 치료제 개발 파이프라인 현황과 각 개발 단계 비교 분석, 약제 표적, 작용기서, 투여 경로, 분자 종류별 치료제 평가, 최신 기업 뉴스와 발표, 후기 단계 및 중지된 프로젝트에 관한 정보 등을 전해드립니다.

목차

Immune Response BioPharma, Inc.의 기본 정보

  • Immune Response BioPharma, Inc.의 개요
  • 주요 정보
  • 기업 정보

Immune Response BioPharma, Inc. : R&D 개요

  • 주요 치료 범위

Immune Response BioPharma, Inc. : 파이프라인 리뷰

  • 개발 단계별 파이프라인 제품
  • 단독요법

Immune Response BioPharma, Inc. : 파이프라인 제품 개요

  • 후기 단계 파이프라인 제품
    • 제3상 제품/병용요법 모달리티
  • 임상 단계 파이프라인 제품
    • 제2상 제품/병용요법 모달리티
    • 제1상 제품/병용요법 모달리티
  • 초기 단계 파이프라인 제품
    • 전임상 제품/병용요법 모달리티

Immune Response BioPharma, Inc. : 치료제 개요

  • IR-103
  • IR-501
  • IR-703
  • IR-502
  • IR-902
  • RemuneX
  • IR-007
  • IR-1000
  • IR-1002
  • IR-2020
  • IR-222
  • IR-444
  • IR-555
  • IR-777
  • IR-888
  • IR-999

Immune Response BioPharma, Inc. : 파이프라인 분석

  • 표적별
  • 투여 경로별
  • 분자 종류별

Immune Response BioPharma, Inc. : 최근의 파이프라인 정보

Immune Response BioPharma, Inc. : 본사 및 자회사 소재지

  • 본사

부록

도표

KSM 15.04.27

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Summary:

Global Markets Direct's, 'Immune Response BioPharma Inc - Product Pipeline Review - 2016', provides an overview of the Immune Response BioPharma Inc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Immune Response BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Immune Response BioPharma Inc
  • The report provides overview of Immune Response BioPharma Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Immune Response BioPharma Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Immune Response BioPharma Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Immune Response BioPharma Inc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Immune Response BioPharma Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Immune Response BioPharma Inc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Immune Response BioPharma Inc Snapshot
    • Immune Response BioPharma Inc Overview
    • Key Facts
  • Immune Response BioPharma Inc - Research and Development Overview
    • Key Therapeutic Areas
  • Immune Response BioPharma Inc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Immune Response BioPharma Inc - Pipeline Products Glance
    • Immune Response BioPharma Inc - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Immune Response BioPharma Inc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Immune Response BioPharma Inc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Immune Response BioPharma Inc - Drug Profiles
    • IR-007 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-1000 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-1002 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-103 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-2020 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-222 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-444 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-502 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-555 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-777 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-888 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-902 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IR-999 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IRE-101 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IRR-102 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IRS-103 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Remune - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Immune Response BioPharma Inc - Pipeline Analysis
    • Immune Response BioPharma Inc - Pipeline Products by Target
    • Immune Response BioPharma Inc - Pipeline Products by Route of Administration
    • Immune Response BioPharma Inc - Pipeline Products by Molecule Type
  • Immune Response BioPharma Inc - Dormant Projects
  • Immune Response BioPharma Inc - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Immune Response BioPharma Inc, Key Facts
  • Immune Response BioPharma Inc - Pipeline by Indication, 2016
  • Immune Response BioPharma Inc - Pipeline by Stage of Development, 2016
  • Immune Response BioPharma Inc - Monotherapy Products in Pipeline, 2016
  • Immune Response BioPharma Inc - Pre-Registration, 2016
  • Immune Response BioPharma Inc - Phase II, 2016
  • Immune Response BioPharma Inc - Phase I, 2016
  • Immune Response BioPharma Inc - Preclinical, 2016
  • Immune Response BioPharma Inc - Pipeline by Target, 2016
  • Immune Response BioPharma Inc - Pipeline by Route of Administration, 2016
  • Immune Response BioPharma Inc - Pipeline by Molecule Type, 2016
  • Immune Response BioPharma Inc - Dormant Developmental Projects,2016

List of Figures

  • Immune Response BioPharma Inc - Pipeline by Top 10 Indication, 2016
  • Immune Response BioPharma Inc - Pipeline by Stage of Development, 2016
  • Immune Response BioPharma Inc - Monotherapy Products in Pipeline, 2016
  • Immune Response BioPharma Inc - Pipeline by Route of Administration, 2016
  • Immune Response BioPharma Inc - Pipeline by Molecule Type, 2016
Back to Top
전화 문의
F A Q